Harvard Apparatus Expands Global Reach with Opening of India Liaison Office

Holliston, Massachusetts, USA: Scientific instrument manufacturer, Harvard Apparatus, is pleased to announce the opening of their India Liaison Office in New Delhi this June, 2011 headed by Dr. Asit Dutta. Based in New Delhi, Dr. Dutta will be responsible for expanding sales of all Harvard Apparatus products through a network of distribution channels across India. [...]

Cell Line Genetics and Ambry Genetics Announce Exclusive Global Agreement For Sales of Ambry Genetics’ StemArray™ and Related Services

MADISON, Wis. & NEW YORK & ALISO VIEJO, Calif. - Cell Line Genetics, Inc., a leader in Stem Cell Quality Assurance services and products, and Ambry Genetics, a global leader in genetic services with a focus on clinical diagnostics and genomics, announced today an exclusive agreement under which Cell Line Genetics will sell the Ambry [...]

Preliminary Injunction Order Against FEI Japan

Tokyo District Court issued a preliminary injunction ordering FEI Japan not to make, sell, assign, lease, offer for assignment or lease, display for the purpose of assignment or lease, or import the products below. The order was to grant Hitachi High-Technologies’ motion, which was filed December 15, 2010, in Tokyo District Court. In the motion, [...]

ProImmune Launches ProArray Ultra: A New Protein and Peptide Microarray Platform with True Analytical Grade Performance

OXFORD, England - ProImmune Ltd., a leader in services for understanding immune responses, announced today that it has launched ProArray Ultra™, a uniquely powerful protein and peptide array platform, which is more sensitive than optimized ECL ELISA. The new platform allows analysis of more than 30,000 peptides or proteins at once, and typically requires only [...]

Moulder Center for Drug Discovery Research Selects Tripos Software for Drug Design

ST LOUIS - Tripos, a leading provider of molecular modeling and informatics software to improve productivity and decision-making in drug discovery, announced today that the Moulder Center for Drug Discovery Research in Temple University’s School of Pharmacy has licensed its entire computer-aided drug design (CADD) and informatics software portfolio to accelerate the drug discovery process. [...]

Pressure BioSciences, Inc. Granted Extension to October 3, 2011 to Regain Compliance With NASDAQ Minimum Stockholders’ Equity Requirement

SOUTH EASTON, Mass. - Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that the Company received a notice from NASDAQ on June 10, 2011 granting it an extension of time until October 3, 2011 to regain compliance with the NASDAQ minimum stockholders' equity requirement of $2.5 million. On April 6, 2011, the Company [...]

QIAGEN Makes Proposal to Fully Acquire Ipsogen, Further Expanding Leadership in Oncology Molecular Diagnostics

VENLO, The Netherlands - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. (Alternext: ALIPS) and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range [...]

BioNanomatrix Opens West Coast Headquarters, Expands Senior Team to Accelerate Commercialization of its Whole Genome Analysis Platform

SAN DIEGO - BioNanomatrix, Inc., the developer of a nanotechnology-based single-molecule imaging platform for whole genome analysis, has established its new headquarters in San Diego. The company has moved into office and laboratory space in the University Science Center, located at 3545 John Hopkins Court along the Torrey Pines Mesa life science corridor. Founded by [...]

Life Technologies Launches Highly Efficient Stem Cell Reprogramming Technology

CARLSBAD, Calif. - Life Technologies Corporation today announced the launch of CytoTune™-iPS Reprogramming Kit -- research technology that provides far improved efficiency over standard methods to develop induced pluripotent stem cells (iPSCs) from human somatic cells. The ability to more easily create larger numbers of these embryonic stem cell-like cells can expedite basic research and [...]

ATCC and Stemgent, Inc. Announce Collaborative Research Agreement to Advance Development of Novel Stem Cell Reagents and Pluripotent Cells

ATCC, the premier biological materials resource and standards organization, and Stemgent, Inc., a leading provider of stem cell research tools, reprogramming reagents and related services, today announced a collaborative research agreement to advance development of novel stem cell reagents and pluripotent cells. Recognizing the need to deliver a level of standardization and reliability in the [...]

Access IBO on Knowledge Center